The practice of mindfulness may be helpful for people trying to reduce their dose of the opioid medication buprenorphine/naloxone (Suboxone), according to Zev Schuman-Olivier, MD, Executive Director, Center for Mindfulness and Compassion, Cambridge Health Alliance.
A growing body of research points to the relationship between alcohol and suicide. Taking steps to reduce the availability of alcohol may help to reduce the number of suicides, says Raul Caetano, M.D., Ph.D., Senior Research Scientist at the Prevention Research Center of the Pacific Institute for Research and Evaluation in Oakland, California.
Many doctors, even those who specialize in addiction treatment, do not have a good understanding of Alcoholics Anonymous (AA) and its benefits for people struggling to give up drinking, says Marc Galanter, M.D., Founding Director of the Division of Alcoholism and Drug Abuse at NYU Langone Medical Center.
While there have been substantial gains on the issue of parity – making addiction and mental health coverage equal to physical health coverage – much work still needs to be done, especially for children, according to Ron Manderscheid, Ph.D., Executive Director of the National Association of County Behavioral Health and Developmental Disability Directors and the National Association for Rural Mental Health.
A new review of studies from around the world finds young people who have greater exposure to alcohol marketing appear to be more likely subsequently to initiate alcohol use and engage in binge and hazardous drinking.
Setting new household rules for teens in treatment for a substance use disorder can be challenging for parents. But it is important because research shows that teens do take their parents’ attitudes, opinions and beliefs into account when they make choices about substance use, says Christopher Hammond, MD, of Johns Hopkins Hospital.
In the past year, federal and state policymakers have taken a number of steps to combat synthetic drugs, also known as “novel psychoactive substances,” according to Jonathan Woodruff, Senior Legislative Attorney at the National Alliance for Model State Drug Laws.
All patients on long-term opioid treatment should be co-prescribed the opioid overdose antidote naloxone, even if they are not considered to be at high risk of an opioid overdose, according to the director of the University of New Mexico Pain Center.
A new program in Pennsylvania called “warm handoff” directly transfers overdose survivors from the hospital emergency department to a drug treatment provider. The program, developed by the state’s Department of Drug and Alcohol Programs (DDAP), is designed to avoid merely giving survivors a phone number to call or setting up a subsequent appointment a day or two later.